Background -Provision of
(ACFA) comprising 59% of the UK population of cystic fibrosis patients over 15 years and 80% over 25 years of age. The response rate was 82%. Results -Two thirds of patients were attending special cystic fibrosis clinics for either adults or adults and children. There were significant differences in the proportion of patients using special cystic fibrosis clinics between regions but not between social class groups. Significant differences between cystic fibrosis and general clinics were noted. Patients attending cystic fibrosis clinics were more likely to have had simple clinical investigations (blood tests, sputum culture, oxygen saturation, chest radiography, weight and lung function measurement) in the previous year. They were also more likely to have received intravenous antibiotics at home, and to have access to paramedical personnel. Patients Conclusions -This survey provides evidence that adults with cystic fibrosis attending special cystic fibrosis clinics receive more intensive care, have better symptom control, and are more satisfied with the service provided than those attending general clinics.
(Thorax 1994;49:300-306) Improvements in survival from cystic fibrosis have resulted in a sustained increase in the prevalence of the disease by approximately 100 patients a year. Most of this increase is in adults,' and already over a quarter of patients are over the age of 30.2 Recent reports suggest that prevalence and prognosis will continue to improve.23 The implication of these observations is that health care services for patients with cystic fibrosis, and particularly adults, will need to expand.
The best way to provide appropriate medical care has, however, been the subject of debate in the UK. In countries where care is organised almost exclusively in specialist centres reported survival rates are superior to those of the UK,>6 suggesting that resources should be invested in specialist clinics. 
QUESTIONNAIRE
The multiple choice questionnaire included questions covering social and demographic information, primary and secondary hospital care, and medication. Severity of disease was estimated using a standard symptom questionnaire with a summary score calculated as the average of five symptoms (breathlessness, cough, sputum, abdominal discomfort, fatigue) each rated on a scale of one to five. This was internally validated against other measures of disease severity such as percentage ideal weight for height, annual sick leave from work, and annual time spent in hospital. A score of < 2 0 represented mild symptoms, 2-1-3-4 represented moderate symptoms, and > 3 5 represented severe symptoms.
Patients were asked to identify the hospital they attended and the type of doctor (paediatrician, chest physician, etc) as well as whether the clinic they attended was only for patients with cystic fibrosis (adults or children) or was a general clinic treating a number of medical or paediatric conditions. They were also asked to recall their contact with paramedical personnel, their current medication, and investigations which had been performed in the previous year at the hospital, reported in the questionnaire. Although there was no direct access to patient records to validate the responses, adults with cystic fibrosis attending hospitals with large cystic fibrosis clinics correctly identified them in 91% of cases.
Patient satisfaction was assessed using several professional and non-professional aspects of care together with an overall rating. The internal validity of responses was high. Although the type of care received relied on recall by patients in this study, adults with cystic fibrosis are generally very aware of their disease, the types of treatment and investigations required, and are responsible for a complex daily regimen of care which requires them to be fully aware of their medication. Most patients have many years' experience of hospital treatment and care. It is possible that socially disadvantaged patients attending general clinics are less accurate in response or recall, but this could not be evaluated.
ACCESS TO SPECIALIST CARE
The British Paediatric Association and the Royal College of Physicians have recommended specialist centres as the basis of medical care for patients with cystic fibrosis.' 2 This survey identified a substantial minority of patients who were not receiving specialist care through cystic fibrosis clinics and significant inequalities in access to such services throughout the UK. One quarter of patients in this sample did not attend a cystic fibrosis specialist doctor or clinic. Patients from manual social classes and in certain areas of the country have lower access, particularly to services for adult patients. Some patients attending special cystic fibrosis clinics still attended paediatricians, which may not be appropriate either for the adult patients or other children on the paediatric wards.
PROCESS OF MEDICAL CARE
This study highlights differences in the delivery of medical care between cystic fibrosis and general clinics. The care given in cystic fibrosis clinics appears to be more intensive, with more direct access to medical advice, more access to home intravenous therapy, more access to dietitians, physiotherapists and other paramedical personnel, more access to basic investigations to monitor progress, and a higher level of therapy, particularly with pan-creatic enzyme supplements. Such differences were independent of overall disease severity. Cystic fibrosis clinics also had more amenities such as activity rooms, and were more likely to allow adult patients to keep and administer their own medication. Patients attending general clinics were more likely to see the consultant, which probably reflects the increased availability of dedicated junior medical staff and research fellows in cystic fibrosis clinics, and did not have any impact on patient satisfaction.
Whilst there is evidence that care in both clinic types is being directed towards those in most need, this study has shown that there are patients who could benefit from more treatment or care, but are not currently receiving it. For example, in the group of patients who were under 85% predicted weight for height, 38 were taking fewer than four enzyme capsules a meal and 41 had not seen a dietitian in the last year.
Many of these process measures relate to aspects of care considered desirable either by learned bodies,2 individual physicians,'3 or the adult patients themselves. '4 15 While not all clinical investigations or treatments are appropriate for all patients, it seems reasonable to expect that basic investigations such as weight, lung function testing, chest radiography, blood tests, oxygen saturation and sputum culture should be performed in the course of a year. Many patients, even those with severe symptoms, could not recall these being performed in the last year.
OUTCOME OF MEDICAL CARE
It is not possible to determine outcome from a single survey such as this, although a follow up study of this cohort is planned in 1994-5, four years after the survey reported here, to assess this more fully. Patients attending specialist clinics had less severe symptoms irrespective of social class, which may reflect more intensive monitoring, treatment and access to specialist personnel, although this difference may be due to psychological as well as physical benefits. There is also evidence that those attending cystic fibrosis clinics have better control of digestive symptoms, avoiding the need for dietary fat restriction because of unacceptable symptoms. Although the lower symptom score in patients attending cystic fibrosis clinics may reflect self selection of patientspatients living a long way from such a clinic may only be able to undertake the journey if they are fit enough -one might also expect the more severely affected individuals to attend cystic fibrosis clinics as tertiary referrals. PATIENT 
SATISFACTION
Patients attending cystic fibrosis clinics were more satisfied with the professional aspects of their care and perceived their care as having improved over the previous five years. Adult patients with cystic fibrosis frequently have good understanding of their disease and are critical of poor standards of knowledge or care.
Overall, over one third did not rate the hospital care they received as good, with particular dissatisfaction expressed with hospital food and social work advice.
HOSPITAL CARE FOR ADULTS WITH CYSTIC FIBROSIS
Expert consensus supports care for adults with cystic fibrosis at specialist centres with defined quality standards,'2 a view shared by most patients themselves,'5 and supported by this study. Whilst such care is available to most patients, there are still substantial numbers for whom it is not. This study has identified inequalities in access to cystic fibrosis clinics, differences in intensity of care between cystic fibrosis and general clinics, and evidence that some patients are receiving suboptimal care.
Although it may be desirable, care which takes place wholly within specialist cystic fibrosis clinics has potential disadvantages. Some adults with cystic fibrosis prefer locally based treatment. Patients have to travel further to attend special cystic fibrosis clinics. Concentration of care in a single centre may lead to reduction in general awareness in other hospitals of cystic fibrosis in adults. If care is centralised there need to be mechanisms for disseminating expertise to local clinicians so that the centre acts as a resource for the region it serves. This might be achieved by the use of formal shared care arrangements with local hospitals, and educational programmes.
Regional health authorities have an average of 100-150 resident adult patients with cystic fibrosis, whereas district health authorities have only 10-20. With such small numbers, specific purchasing of care by district health authorities may be difficult. Leaving their care to the extracontractual referral mechanism may lead to further difficulties in access to specialist clinics and may compromise the planning and development of specialist services. This study has shown some evidence that care in special cystic fibrosis clinics may be of benefit to patients, with improved symptom control and more intensive treatment and monitoring. Whether the latter confers significant clinical benefit and improves social outcome requires prospective evaluation in the planned follow up survey. Patients are certainly more satisfied with this type of care. If purchasing decisions are to be made in favour of cystic fibrosis clinic care, patient numbers suggest that this might be most appropriately done above single district level.
This study provides evidence that a substantial minority of adults with cystic fibrosis still do not receive care in special cystic fibrosis clinics as recommended by the Royal College of Physicians.2 There is evidence that the type of care differs between special cystic fibrosis clinics and general clinics, with greater intensity of treatment and investigation, greater access to paramedical team members, and better symptom control in those attending special cystic fibrosis clinics. Patient satisfaction is higher in those attending cystic fibrosis clinics. This provides supporting evidence for the concept of specialist centres of treatment, and highlights areas for improvement, although the question of whether specialist care confers benefit in terms of clinical status, social outcome, and survival remains to be answered. It is hoped that those responsible for purchasing health care, and those who provide care for adults with cystic fibrosis, will recognise the challenges it poses to provide high quality care for all adult patients with cystic fibrosis. 
